Hudson Bay Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 127,070 shares of RXRX stock, worth $531,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,070
Previous 77,500
63.96%
Holding current value
$531,152
Previous $523,000
28.49%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$146 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$135 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$102 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$72.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$61.3 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $754M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...